PUBLISHER: Bizwit Research & Consulting LLP | PRODUCT CODE: 1226463
PUBLISHER: Bizwit Research & Consulting LLP | PRODUCT CODE: 1226463
Global Cancer Registry Software Market is valued approximately USD XX billion in 2021 and is anticipated to grow with a healthy growth rate of more than XX% over the forecast period 2022-2029. Cancer registry is a computerized database which uses software solutions to organize, gather and store data of the cancer patients and evaluate cancer-specific upshots, situations and drug/medical device exposure. Growing number of cancer cases, increasing adoption of EHR, favorable government programs towards cancer and growing use of cancer patient registry data for post-marketing surveillance are the few factors responsible for high CAGR of the market over the forecast period.
The rising number of cancer cases globally support the market growth because it helps in automates data gathering for federal and state registries, which aids in tracking the efficacy of various treatment options. Additionally, the information gathered by the state registers assists in a better understanding and treatment of the disease. For instance, according to International Agency for Research on Cancer (IARC), approx. 19.3 million new cases of cancer are reported in UN regions in 2020. In the year 2040, it is anticipated that there would be about 28.4 million incident cases. Additionally, increasing number of accountable care organizations is anticipated to create the lucrative opportunity for the marker during forecast period. However, the privacy and data security-related concerns may stifles market growth throughout the forecast period of 2022-2029.
The key regions considered for the Global Cancer Registry Software Market study includes Asia Pacific, North America, Europe, Latin America, and Rest of the World. North America is the dominating region across the world in terms of market share, owing to the rising prevalence of cancer, government funding initiatives to encourage the development of cancer registries and high investments in healthcare IT across the region. Whereas, Asia Pacific is also anticipated to exhibit highest growth rate over the forecast period, owing to factors such as rising prevalence of cancer, rising public private investment for healthcare infrastructure development would create lucrative growth prospects for the Cancer Registry Software market across Asia Pacific region.
The objective of the study is to define market sizes of different segments & countries in recent years and to forecast the values to the coming years. The report is designed to incorporate both qualitative and quantitative aspects of the industry within countries involved in the study.
The report also caters detailed information about the crucial aspects such as driving factors & challenges which will define the future growth of the market. Additionally, it also incorporates potential opportunities in micro markets for stakeholders to invest along with the detailed analysis of competitive landscape and product offerings of key players. The detailed segments and sub-segment of the market are explained below:
List of tables and figures and dummy in nature, final lists may vary in the final deliverable
List of figures
List of tables and figures and dummy in nature, final lists may vary in the final deliverable